Cantor Fitzgerald Reaffirms “Neutral” Rating for Universal Health Services (NYSE:UHS)

Universal Health Services (NYSE:UHS)‘s stock had its “neutral” rating restated by stock analysts at Cantor Fitzgerald in a report released on Tuesday,Benzinga reports. They currently have a $194.00 price target on the health services provider’s stock. Cantor Fitzgerald’s target price indicates a potential upside of 21.71% from the company’s current price.

Several other equities analysts have also recently commented on the company. Barclays cut their price target on Universal Health Services from $179.00 to $168.00 and set an “equal weight” rating for the company in a report on Tuesday. JPMorgan Chase & Co. lowered their price objective on Universal Health Services from $235.00 to $205.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 20th. TD Cowen cut their target price on Universal Health Services from $230.00 to $197.00 and set a “buy” rating for the company in a research note on Monday, June 22nd. Raymond James Financial lowered Universal Health Services from an “outperform” rating to a “market perform” rating in a research note on Wednesday, April 29th. Finally, Stephens reduced their target price on Universal Health Services from $235.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 29th. Five investment analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, Universal Health Services has a consensus rating of “Hold” and a consensus price target of $213.00.

Universal Health Services Stock Up 2.3%

Shares of UHS opened at $159.40 on Tuesday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.01 and a current ratio of 1.08. The company has a 50-day simple moving average of $150.38 and a 200-day simple moving average of $179.11. Universal Health Services has a 52 week low of $140.08 and a 52 week high of $246.32. The firm has a market capitalization of $9.65 billion, a P/E ratio of 6.64, a P/E/G ratio of 0.83 and a beta of 1.07.

Universal Health Services (NYSE:UHS) last released its earnings results on Tuesday, July 28th. The health services provider reported $5.98 earnings per share for the quarter, topping analysts’ consensus estimates of $5.94 by $0.04. Universal Health Services had a return on equity of 19.57% and a net margin of 8.56%.The business had revenue of $4.64 billion for the quarter, compared to the consensus estimate of $4.58 billion. During the same period last year, the business earned $5.35 earnings per share. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. On average, equities research analysts expect that Universal Health Services will post 23.44 earnings per share for the current year.

Institutional Investors Weigh In On Universal Health Services

Large investors have recently modified their holdings of the stock. Elyxium Wealth LLC acquired a new position in shares of Universal Health Services in the 4th quarter worth approximately $25,000. Harbor Capital Advisors Inc. acquired a new stake in Universal Health Services in the 4th quarter valued at $26,000. Founders Capital Management acquired a new stake in Universal Health Services in the 4th quarter valued at $28,000. Elevation Wealth Partners LLC grew its position in Universal Health Services by 503.1% in the second quarter. Elevation Wealth Partners LLC now owns 193 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 161 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new stake in Universal Health Services in the second quarter valued at $29,000. 86.05% of the stock is currently owned by institutional investors.

Universal Health Services News Roundup

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: UHS reported second-quarter adjusted earnings of $5.98 per share, above the $5.94 consensus estimate and up from $5.35 a year earlier. Revenue rose 8.3% year over year to $4.64 billion, exceeding expectations of $4.58 billion. UHS second-quarter financial results
• Positive Sentiment: The quarterly performance reflected continued operating growth, with net income attributable to UHS increasing to $358.4 million from $353.2 million in the prior-year period. Universal Health Services announces financial results
• Neutral Sentiment: Barclays lowered its price target for Universal Health Services to $168 from $179 and maintained an “equal weight” rating. The revised target still implies approximately 5.4% upside from the referenced $159.40 price, but the target cut signals more limited near-term expectations. Benzinga coverage
• Negative Sentiment: UHS revised its 2026 adjusted EPS guidance to $22.28-$23.65, with the midpoint below the $23.44 analyst consensus. Revenue guidance of $18.5 billion-$18.8 billion was broadly consistent with expectations, making the earnings outlook the main concern. Reuters report on UHS forecast reduction
• Negative Sentiment: Management cited changes and uncertainty involving Medicaid supplemental payment programs. Investors are concerned that reimbursement pressure could reduce hospital profitability, which helps explain the sharp decline in UHS shares in extended trading despite the quarterly beat. UHS sales and stock reaction

About Universal Health Services

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.